+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Diasorin - logo

DiaSorin develops and manufactures reagents for in vitro diagnostics. It has products in the fields of infectious disease, hepatitis, endocrinology, bone and mineral metabolism, cancer, brain injury, cardiac, therapeutic drug monitoring, and autoimmunity. The company was formerly known as ImmunoNuclear Corporation. Operating through two dozen subsidiaries, DiaSorin has sales organizations in more than 60 countries.The company was founded in 1975 and is based in Stillwater, Minnesota. It operates as a subsidiary of DiaSorin S.p.A.

From
From
In Vitro Diagnostics - Global Strategic Business Report - Product Thumbnail Image

In Vitro Diagnostics - Global Strategic Business Report

  • Report
  • June 2025
  • 181 Pages
  • Global
From
Radioimmunoassays - Global Strategic Business Report - Product Thumbnail Image

Radioimmunoassays - Global Strategic Business Report

  • Report
  • June 2025
  • 193 Pages
  • Global
From
Genomics in Cancer Care Market Report 2025 - Product Thumbnail Image

Genomics in Cancer Care Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
Infectious Disease Market 2025-2029 - Product Thumbnail Image

Infectious Disease Market 2025-2029

  • Report
  • February 2025
  • 223 Pages
  • Global
From
From
From
In Vitro Diagnostics Business Outlook, 2024 (6 updates) - Product Thumbnail Image

In Vitro Diagnostics Business Outlook, 2024 (6 updates)

  • Report
  • January 2024
  • 35 Pages
  • Global
From
From
From
From
Sexually Transmitted Diseases (STD) Treatment Market 2024-2028 - Product Thumbnail Image

Sexually Transmitted Diseases (STD) Treatment Market 2024-2028

  • Report
  • October 2024
  • 145 Pages
  • Global
From
From
Loading Indicator